[Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000188:drug therapy*; D000583:Amikacin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D007945:Leukemia, Lymphoid / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology
D007612:Kanamycin; D000583:Amikacin
Traitement par l'amikacine des complications fébriles survenant en phase neutropénique des hémopathies aiguës.